Haihe Biopharma Co., a Chinese pharmaceutical company specialized in innovative oncology drugs, has secured a US$146.6 million new round of investment led by China-focused private equity firm Huagai Capital, said Haihe Biopharma in a statement released on Monday. According to the statement, a group of investors also participated in the new round, including Chinese principal […]

Chinese Oncology-Focused Innovative Drugs Developer Haihe Biopharma Nets $146M appeared first on China Money Network.